Bubs Australia shares set for 15% weekly gain on FDA approval for infant formula products
11/09/2026 02:13
BUZZ-Bubs Australia shares set for 15% weekly gain on FDA approval for infant formula products ** Shares of Bubs Australia BUB.AX drop 8% to A$0.115 on the day, but headed to finish the week 15% higher
** Shares rallied earlier this week after the company bagged permanent U.S. FDA approval for Bubs Goat, Bubs 365 Day Grass Fed and Bubs Essential infant formula products
** Shares set to post another weekly gain; added 19% last week
** YTD, BUB shares down 16.4%
(Reporting by Nichiket Sunil in Bengaluru)
Recent news on Bubs Australia
See all newsBubs Australia hits near two-month low as quarterly revenue declines
Bubs Australia shares set for 15% weekly gain on FDA approval for infant formula products
Bubs Australia extends rally after infant formulas get US FDA approval
Bubs Australia gets permanent FDA nod for infant formula sales in US, shares jump (updated)
Bubs Australia secures permanent FDA nod for infant formula sales in US, shares jump